Trials / Completed
CompletedNCT02862795
Human Papillomavirus Anal Infection
Human PapillomaVirus (HPV) Anal Infection: Study of Prevalence and Risk Factors Among 1000 Patients Benefiting From a Colonoscopy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 500 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Besancon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Human papillomavirus (HPV) are involved in up to 95 % of anal canal neoplastic lesions. Little is known about HPV carriage in anal canal previous to cancer occurrence in the population and pre-neoplastic lesions, and their risk factors. PAPILLAN is a prospective study that aims to study HPV infection (HPV low grade and high grade genotypes) prevalence in anal canal in a population non selected by its HIV status. In that purpose patients are prospectively recruited in a french university hospital gastroenterology unit and anal smears are collected during a colonoscopy with cytobrush.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | HPV detection in anal canal samples | Additional anal taking during the colonoscopy with cytobrush |
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2016-06-01
- Completion
- 2016-06-01
- First posted
- 2016-08-11
- Last updated
- 2016-08-11
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02862795. Inclusion in this directory is not an endorsement.